Cargando…
Preliminary clinical assessment and non- toxicity evaluation of an ayurvedic formulation BGR-34 in NIDDM
In view of the overall health impact of NIDDM, inventers understand the necessity of improving glycemic control in adults with type 2 diabetes. BGR-34 provides an effective treatment option for adults with type 2 diabetes who have been inadequately controlled on lifestyle with or without other oral...
Autores principales: | Gupta, B.P., Sharma, I., Kohli, N., Sharma, S., Rathi, A., Sharma, A.K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174273/ https://www.ncbi.nlm.nih.gov/pubmed/30302331 http://dx.doi.org/10.1016/j.jtcme.2017.11.004 |
Ejemplares similares
-
TLC-MS Bioautography-Based Identification of Free-Radical
Scavenging, α-Amylase, and α-Glucosidase
Inhibitor Compounds of Antidiabetic Tablet BGR-34
por: Gaurav,, et al.
Publicado: (2020) -
deBGR: an efficient and near-exact representation of the weighted de Bruijn graph
por: Pandey, Prashant, et al.
Publicado: (2017) -
Antidiabetic Activity of an Ayurvedic Formulation Chaturmukha Rasa: A Mechanism Based Study
por: Sharma, Akansha, et al.
Publicado: (2019) -
Preliminary Screening of a Classical Ayurvedic Formulation for Anticonvulsant Activity
por: Dhar, Arnab, et al.
Publicado: (2016) -
Antidiabetic activity of Chandraprabha vati – A classical Ayurvedic formulation
por: Wanjari, Manish M., et al.
Publicado: (2016)